NCT03414255: A trial that was reported late by MiMedx Group, Inc.
This trial has reported, although it was 653 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03414255 |
|---|---|
| Title | A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial Of The Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Achilles Tendonitis |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 9, 2018 |
| Completion date | March 30, 2021 |
| Required reporting date | March 30, 2022, midnight |
| Actual reporting date | Jan. 12, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 653 |